Clinical Trials Browser

Terminated × Mesothelioma × Bevacizumab × Clear all

NCT00604461 2017-03-23

Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)

Phase 1/2 Terminated

13 enrolled 7 charts

Other solid neoplasmThoracic

Mesothelioma